Question 1

What is Esther Rajavelu?

Accepted Answer

Esther Rajavelu is a Person.

Question 2

How often does Esther Rajavelu appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 15 articles.

Question 3

When was Esther Rajavelu first tracked by Ergen?

Accepted Answer

First tracked on Jul 14, 2026.

Question 4

When was Esther Rajavelu last mentioned in news?

Accepted Answer

Last active on Jul 27, 2026.

Question 5

What is Esther Rajavelu's current news sentiment?

Accepted Answer

Aggregate sentiment score: 8 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Esther Rajavelu in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Esther Rajavelu?

Accepted Answer

Spero Therapeutics appoints new CMO (Jul 27, 2026, 6 articles).

Question 8

How did the "Spero Therapeutics appoints new CMO" event impact Esther Rajavelu?

Accepted Answer

Esther Rajavelu, as CEO, welcomed the new CMO and highlighted her expertise for advancing Spero's clinical strategy.

Question 9

How did the "Spero $105M royalty financing" event impact Esther Rajavelu?

Accepted Answer

CEO Esther Rajavelu led the strategic financing and immunology pivot.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.